Cleared Traditional

K042849 - CARDIO SPECTRUM DIAGNOSTIC SYSTEM (CSD)

K042849 is an FDA 510(k) clearance for CARDIO SPECTRUM DIAGNOSTIC SYSTEM (CSD), manufactured by Cardiobiomedical Corporation. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K042849 · Cardiobiomedical Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2005
Decision
90d
Days
Class 2
Risk

K042849 is an FDA 510(k) clearance for the CARDIO SPECTRUM DIAGNOSTIC SYSTEM (CSD). Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Cardiobiomedical Corporation (Natick, US). The FDA issued a Cleared decision on January 13, 2005 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardiobiomedical Corporation devices

FDA 510(k) Submission Details - K042849

510(k) Number K042849 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 2004
Decision Date January 13, 2005
Days to Decision 90 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 125d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 331
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K042849.
CARTO XP EP NAVIGATION SYSTEM, SOFTWARE VERISON 8
K042999 · Biosense Webster, Inc. · Mar 2005
HORIZON ANGIO CATHLAB
K043564 · Mennen Medical , Ltd. · Jan 2005
MODIFICATION TO: RADIANALYZER, MODEL 12711
K042628 · Radi Medical Systems AB · Jan 2005
SYNESCOPE, EASYSCOPE, SYNECOM, HOLTERREADER
K042002 · Ela Medical, Inc. · Oct 2004
T-WAVE ALTERNANS (TWA) ALGORITHM OPTION
K032513 · Ge Medical Systems Information Technologies · Oct 2003
MODIFICATION TO: MAC-LAB/CARDIOLAB EP/COMBOLAB SYSTEM
K032577 · Ge Medical Systems Information Technologies · Oct 2003